Naoero vs United States of America: Proportion of the target population who received
Naoero
99.0%
in 2024
United States of America
95.0%
in 2024
Naoero rank
1st
United States of America rank
2nd
Proportion of the target population who received over time
- Naoero
- United States of America
How they compare
Naoero currently reports 99.0% against 95.0% in United States of America, a difference of 4.0%.
The two have swapped places 6 times across 24 shared years of data; in 2001 it was Naoero ahead.
Naoero ranks 1st and United States of America ranks 2nd of 193 countries.
Across the 3 decades both report, Naoero averaged higher in 2 and United States of America in 1.
Head to head by decade
| Decade | Naoero | United States of America | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 83.0% | 86.3% | 3.3% | United States of America |
| 2010s | 93.7% | 92.3% | 1.4% | Naoero |
| 2020s | 98.6% | 95.0% | 3.6% | Naoero |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of the target population who received, Naoero or United States of America?
- Naoero, at 99.0% against 95.0% in United States of America as of 2024.
- What is the difference in proportion of the target population who received between Naoero and United States of America?
- 4.0%, with Naoero ahead.
- How many years of comparable data are there for Naoero and United States of America?
- 24 years are reported by both, from 2001 to 2024.
- How do Naoero and United States of America rank globally for proportion of the target population who received?
- Naoero ranks 1st and United States of America ranks 2nd of 193 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.